Rosenblatt Securities cuts Dolby Laboratories target price to $80 from $85
DLB•Rosenblatt Securities cut its target price for Dolby Laboratories to $80 from $85.
Related News

CorMedix CEO Joseph Todisco reports acquisition of $391,200 in common shares
CRMD•

XCF Global names Wray Thorn president and CFO
SAFX•

GT Biopharma posts Q3 net loss as R&D expenses rise
GTBP•

AirJoule Technologies completes BitSink acquisition, sets 2027 revenue outlook
AIRJ•

Alibaba details new AI safeguards as Chinese developers step up test disclosures
BABA•